Skip to main content
OpenTrials
Completed

NCT Number: NCT00618865

Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy

Whether high-dose omega-3 fatty acids supplement would be an effective treatment in patients with major depressive disorder during pregnancy and breast-feeding.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depressive Disorder Depressive Disorder, Major Mental Disorders Mood Disorders

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible participants were pregnant women, aged 18 to 40 years, with major depressive disorder onset between their 16th week (second trimester) and 32nd week (third trimester) of gestation at the Department of Obstetrics.

Exclusion criteria

  • Subjects were excluded with a DSM-IV diagnosis of bipolar disorders, psychotic disorders, substance abuse or dependence for at least 3 months, or any Axis-II diagnosis of borderline or antisocial personality disorder.

Treatment and study plan

Omega-3 fatty acids

Dietary Supplement

Sponsors and collaborators

Lead sponsor

National Science and Technology Council, Taiwan

Other Gov

Registry information

Official study title

Omega-3 Polyunsaturated Fatty Acids in Women With Major Depressive Disorders During Pregnancy

Important dates

Study start
2004
Primary completion
2004
Study completion
2004
First posted
Feb 20, 2008
Registry last updated
Feb 20, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.